Cadila Healthcare informs about analyst meet

23 Aug 2021 Evaluate
Cadila Healthcare has informed that the company has arranged a call with the analysts and investors to discuss about the receipt of Emergency Use Authorization of ZyCoV-D vaccine today August 23, 2021 between 3.00 pm to 3.30 pm Sharvil P. Patel, Managing Director of the Company will be hosting the call. Details of the call are enclosed.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

992.95 8.20 (0.83%)
15-May-2024 09:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1543.65
Dr. Reddys Lab 5891.00
Cipla 1402.00
Zydus Lifesciences 992.95
Lupin 1605.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.